EDGAR Filing Documents for 0001607062-19-000073

Form 8-K - Current report:

SEC Accession No. 0001607062-19-000073

Filing Date

2019-02-15

Accepted

2019-02-14 18:45:16

Documents

Period of Report

2019-02-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	gnbt021419form8k.htm	8-K	36527
2	EXHIBIT 4.1	ex4_1.htm	EX-4.1	137200
3	EXHIBIT 4.2	ex4_2.htm	EX-4.2	128858
4	EXHIBIT 4.3	ex4_3.htm	EX-4.3	69315
5	EXHIBIT 4.4	ex4_4.htm	EX-4.4	79509
	Complete submission text file	0001607062-19-000073.txt		452687

Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025

Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)